Romano P S, Waitzman N J, Scheffler R M, Pi R D
Department of Medicine, University of California, Davis, School of Medicine, Sacramento, USA.
Am J Public Health. 1995 May;85(5):667-76. doi: 10.2105/ajph.85.5.667.
The purpose of this study was to compare the economic costs and benefits of fortifying grain with folic acid to prevent neural tube defects.
A cost-benefit analysis based on the US population, using the human capital approach to estimate the costs associated with preventable neural tube defects, was conducted.
Under a range of assumptions about discount rates, baseline folate intake, the effectiveness of folate in preventing neural tube defects, the threshold dose that minimizes risk, and the cost of surveillance, fortification would likely yield a net economic benefit. The best estimate of this benefit is $94 million with low-level (140 micrograms [mcg] per 100 g grain) fortification and $252 million with high-level (350 mcg/100 g) fortification. The benefit-to-cost ratio is estimated at 4.3:1 for low-level and 6.1:1 for high-level fortification.
By averting costly birth defects, folic acid fortification of grain in the United States may yield a substantial economic benefit. We may have underestimated net benefits because of unmeasured costs of neural tube defects and unmeasured benefits of higher folate intake. We may have overestimated net benefits if the cost of neurologic sequelae related to delayed diagnosis of vitamin B12 deficiency exceeds our projection.
本研究旨在比较谷物强化叶酸预防神经管缺陷的经济成本和效益。
采用基于美国人群的成本效益分析,运用人力资本法估算与可预防神经管缺陷相关的成本。
在一系列关于贴现率、基线叶酸摄入量、叶酸预防神经管缺陷的有效性、使风险最小化的阈值剂量以及监测成本的假设下,强化叶酸可能会产生净经济效益。这种效益的最佳估计是,低水平(每100克谷物含140微克[mcg])强化为9400万美元,高水平(每100克含350微克)强化为2.52亿美元。低水平强化的效益成本比估计为4.3:1,高水平强化为6.1:1。
通过避免代价高昂的出生缺陷,美国谷物强化叶酸可能会产生巨大的经济效益。由于未衡量的神经管缺陷成本和未衡量的较高叶酸摄入量的益处,我们可能低估了净效益。如果与维生素B12缺乏延迟诊断相关的神经后遗症成本超过我们的预测,我们可能高估了净效益。